HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 493-504 of 1,979
Drug study icon
CompletedEUCTR 2005-002131-27

Efficacy and safety of eslicarbazepine acetate (BIA 2-093) in acute manic episodes associated with Bipolarity type I in a double-blind, randomised, dose-titration, placebo-controlled, multicenter ...

Official study title

Efficacy and safety of eslicarbazepine acetate (BIA 2-093) in acute manic episodes associated with bipolar I disorder in a double-blind, randomised, dose-titration, placebo-controlled, multicenter ...

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Austria
BipolarityHistorical research record
Countries
Austria, Czechia, Germany, + 2 others
Sponsor
BIAL - Portela & Ca, S.A.
Behavioral study icon
CompletedNCT06504342

Clocks in Sync - Circadian Rhythm and Bipolar Mania

Official study title

Pilot Trial of Time Restricted Eating to Support an Adaptive Innovative Clinical Trial of Combined Chronotherapies for Mania in Bipolar Disorder

This study has finished and is no longer accepting participants.

In Ottawa
BipolarityDevice studyAges 16+
Countries
Canada
Sponsor
Ottawa Hospital Research Institute
Device study icon
CompletedNCT05206747

Ottawa Sunglasses at Night for Mania Study

What is this study about?

Researchers compared glasses that block blue light and a simulated comparison procedure to find out how the approaches affected manic symptoms in people with bipolarity during a manic episode.

This study has finished and is no longer accepting participants.

In Ottawa
BipolarityDevice studyAges 18–70
Countries
Canada
Sponsor
Ottawa Hospital Research Institute
Drug study icon
CompletedNCT01058096

Safety and Efficacy of Cariprazine for Mania

What is this study about?

Researchers compared Cariprazine and placebo to find out how the approaches affected manic symptoms in people with bipolarity type I during a manic episode.

This study has finished and is no longer accepting participants.

Multiple locations, including Long Beach
BipolarityMedication studyAges 18–65
Countries
United States, India
Sponsor
Forest Laboratories
Drug study icon
CompletedNCT00278772

Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomania or Mild Mania

Official study title

"A Randomized, Double-Blind, Placebo-Controlled Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania"

This study has finished and is no longer accepting participants.

In Cincinnati
BipolarityMedication studyAges 18+
Countries
United States
Sponsor
Lindner Center of HOPE
Other study type icon
CompletedNCT00001772

Evaluation of people with Rapid Cycling Bipolarity (RCBD)

Official study title

Evaluation of Patients With Rapid Cycling Bipolar Disorder

This study has finished and is no longer accepting participants.

In Bethesda
BipolarityObservational study
Countries
United States
Sponsor
National Institute of Mental Health (NIMH) (Government agency)
Other study type icon
CompletedNCT04812379

Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP)

Official study title

Abilify Prolonged Release Aqueous Suspension for Intramuscular Injection Specified Drug-use Results Survey (Prevention of Recurrence/relapse of Mood Episodes in Bipolar I Disorder)

This study has finished and is no longer accepting participants.

In Osaka
BipolarityObservational study
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd. (Pharmaceutical company)
Other study type icon
CompletedNCT00001652

The Evaluation and Follow-up of people with Bipolarity

Official study title

The Evaluation and Naturalistic Follow-up of Patients With Bipolar Disorder

This study has finished and is no longer accepting participants.

In Bethesda
BipolarityObservational study
Countries
United States
Sponsor
National Institute of Mental Health (NIMH) (Government agency)
Drug study icon
Recruitment unclearEUCTR 2012-000778-46

Elucidation of Lithium Working Mechanism in Bipolarity by means of Multi Modal Brain Imaging (LiBiDi)

Official study title

Elucidation of Lithium Working Mechanism in Bipolar Disorder by means of Multi Modal Brain Imaging (LiBiDi)

Original registry wording; source language not specified.

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Germany
BipolarityHistorical research record
Countries
Germany
Sponsor
Forschungszentrum Jülich GmbH

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.